HEADER HYDROLASE 05-MAY-06 2GWO TITLE CRYSTAL STRUCTURE OF TMDP COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN PHOSPHATASE 13; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: TESTIS- AND SKELETAL-MUSCLE-SPECIFIC DSP, DUAL SPECIFICITY COMPND 5 PHOSPHATASE SKRP4, TMDP; COMPND 6 EC: 3.1.3.48, 3.1.3.16; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DUSP13, TMDP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALPHA/BETA, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.J.KIM,S.E.RYU,J.H.KIM REVDAT 3 13-MAR-24 2GWO 1 REMARK REVDAT 2 24-FEB-09 2GWO 1 VERSN REVDAT 1 20-MAR-07 2GWO 0 JRNL AUTH S.J.KIM,D.G.JEONG,T.S.YOON,J.H.SON,S.K.CHO,S.E.RYU,J.H.KIM JRNL TITL CRYSTAL STRUCTURE OF HUMAN TMDP, A TESTIS-SPECIFIC DUAL JRNL TITL 2 SPECIFICITY PROTEIN PHOSPHATASE: IMPLICATIONS FOR SUBSTRATE JRNL TITL 3 SPECIFICITY JRNL REF PROTEINS V. 66 239 2007 JRNL REFN ISSN 0887-3585 JRNL PMID 17044055 JRNL DOI 10.1002/PROT.21197 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 29446 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1443 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5382 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GWO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1000037640. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-18B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1. REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29452 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5M NACL, 10% ETOH, 10MM DTT, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.12000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 SER A 3 REMARK 465 LEU A 4 REMARK 465 GLN A 5 REMARK 465 LYS A 6 REMARK 465 GLN A 7 REMARK 465 ASP A 8 REMARK 465 LEU A 9 REMARK 465 ARG A 10 REMARK 465 ARG A 11 REMARK 465 PRO A 12 REMARK 465 LYS A 13 REMARK 465 ILE A 14 REMARK 465 HIS A 15 REMARK 465 GLY A 16 REMARK 465 ALA A 17 REMARK 465 VAL A 18 REMARK 465 GLN A 19 REMARK 465 ALA A 20 REMARK 465 SER A 21 REMARK 465 PRO A 22 REMARK 465 TYR A 23 REMARK 465 GLN A 24 REMARK 465 GLU A 194 REMARK 465 THR A 195 REMARK 465 GLY A 196 REMARK 465 ARG A 197 REMARK 465 PHE A 198 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 465 SER B 3 REMARK 465 LEU B 4 REMARK 465 GLN B 5 REMARK 465 LYS B 6 REMARK 465 GLN B 7 REMARK 465 ASP B 8 REMARK 465 LEU B 9 REMARK 465 ARG B 10 REMARK 465 ARG B 11 REMARK 465 PRO B 12 REMARK 465 LYS B 13 REMARK 465 ILE B 14 REMARK 465 HIS B 15 REMARK 465 GLY B 16 REMARK 465 ALA B 17 REMARK 465 VAL B 18 REMARK 465 GLN B 19 REMARK 465 ALA B 20 REMARK 465 SER B 21 REMARK 465 PRO B 22 REMARK 465 TYR B 23 REMARK 465 GLN B 24 REMARK 465 GLU B 194 REMARK 465 THR B 195 REMARK 465 GLY B 196 REMARK 465 ARG B 197 REMARK 465 PHE B 198 REMARK 465 MET C 1 REMARK 465 ASP C 2 REMARK 465 SER C 3 REMARK 465 LEU C 4 REMARK 465 GLN C 5 REMARK 465 LYS C 6 REMARK 465 GLN C 7 REMARK 465 ASP C 8 REMARK 465 LEU C 9 REMARK 465 ARG C 10 REMARK 465 ARG C 11 REMARK 465 PRO C 12 REMARK 465 LYS C 13 REMARK 465 ILE C 14 REMARK 465 HIS C 15 REMARK 465 GLY C 16 REMARK 465 ALA C 17 REMARK 465 VAL C 18 REMARK 465 GLN C 19 REMARK 465 ALA C 20 REMARK 465 SER C 21 REMARK 465 PRO C 22 REMARK 465 TYR C 23 REMARK 465 GLN C 24 REMARK 465 MET D 1 REMARK 465 ASP D 2 REMARK 465 SER D 3 REMARK 465 LEU D 4 REMARK 465 GLN D 5 REMARK 465 LYS D 6 REMARK 465 GLN D 7 REMARK 465 ASP D 8 REMARK 465 LEU D 9 REMARK 465 ARG D 10 REMARK 465 ARG D 11 REMARK 465 PRO D 12 REMARK 465 LYS D 13 REMARK 465 ILE D 14 REMARK 465 HIS D 15 REMARK 465 GLY D 16 REMARK 465 ALA D 17 REMARK 465 VAL D 18 REMARK 465 GLN D 19 REMARK 465 ALA D 20 REMARK 465 SER D 21 REMARK 465 PRO D 22 REMARK 465 TYR D 23 REMARK 465 GLN D 24 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS C 138 CB CYS C 138 SG -0.126 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 138 CA - CB - SG ANGL. DEV. = 6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 38 51.75 -102.79 REMARK 500 GLN A 84 -134.03 -117.64 REMARK 500 THR A 87 -75.49 -87.75 REMARK 500 SER A 96 61.04 -103.73 REMARK 500 ASP A 106 57.31 -101.60 REMARK 500 CYS A 138 -155.70 -119.12 REMARK 500 SER A 143 -74.78 -121.58 REMARK 500 CYS A 175 78.00 -157.42 REMARK 500 GLN B 84 -124.96 -110.27 REMARK 500 THR B 87 -72.81 -103.65 REMARK 500 CYS B 138 -159.90 -132.05 REMARK 500 SER B 143 -72.01 -119.40 REMARK 500 ASN B 158 51.02 39.66 REMARK 500 CYS B 175 73.82 -158.83 REMARK 500 GLN C 84 -123.18 -120.00 REMARK 500 THR C 87 -72.74 -105.50 REMARK 500 CYS C 138 -151.32 -126.58 REMARK 500 SER C 143 -76.44 -120.51 REMARK 500 CYS C 175 85.67 -161.88 REMARK 500 GLN D 84 -137.79 -117.23 REMARK 500 THR D 87 -77.87 -87.67 REMARK 500 CYS D 138 -147.37 -123.00 REMARK 500 CYS D 175 76.22 -170.94 REMARK 500 REMARK 500 REMARK: NULL DBREF 2GWO A 1 198 UNP Q9UII6 DUS13_HUMAN 1 198 DBREF 2GWO B 1 198 UNP Q9UII6 DUS13_HUMAN 1 198 DBREF 2GWO C 1 198 UNP Q9UII6 DUS13_HUMAN 1 198 DBREF 2GWO D 1 198 UNP Q9UII6 DUS13_HUMAN 1 198 SEQADV 2GWO CYS A 156 UNP Q9UII6 TYR 156 SEE REMARK 999 SEQADV 2GWO CYS B 156 UNP Q9UII6 TYR 156 SEE REMARK 999 SEQADV 2GWO CYS C 156 UNP Q9UII6 TYR 156 SEE REMARK 999 SEQADV 2GWO CYS D 156 UNP Q9UII6 TYR 156 SEE REMARK 999 SEQRES 1 A 198 MET ASP SER LEU GLN LYS GLN ASP LEU ARG ARG PRO LYS SEQRES 2 A 198 ILE HIS GLY ALA VAL GLN ALA SER PRO TYR GLN PRO PRO SEQRES 3 A 198 THR LEU ALA SER LEU GLN ARG LEU LEU TRP VAL ARG GLN SEQRES 4 A 198 ALA ALA THR LEU ASN HIS ILE ASP GLU VAL TRP PRO SER SEQRES 5 A 198 LEU PHE LEU GLY ASP ALA TYR ALA ALA ARG ASP LYS SER SEQRES 6 A 198 LYS LEU ILE GLN LEU GLY ILE THR HIS VAL VAL ASN ALA SEQRES 7 A 198 ALA ALA GLY LYS PHE GLN VAL ASP THR GLY ALA LYS PHE SEQRES 8 A 198 TYR ARG GLY MET SER LEU GLU TYR TYR GLY ILE GLU ALA SEQRES 9 A 198 ASP ASP ASN PRO PHE PHE ASP LEU SER VAL TYR PHE LEU SEQRES 10 A 198 PRO VAL ALA ARG TYR ILE ARG ALA ALA LEU SER VAL PRO SEQRES 11 A 198 GLN GLY ARG VAL LEU VAL HIS CYS ALA MET GLY VAL SER SEQRES 12 A 198 ARG SER ALA THR LEU VAL LEU ALA PHE LEU MET ILE CYS SEQRES 13 A 198 GLU ASN MET THR LEU VAL GLU ALA ILE GLN THR VAL GLN SEQRES 14 A 198 ALA HIS ARG ASN ILE CYS PRO ASN SER GLY PHE LEU ARG SEQRES 15 A 198 GLN LEU GLN VAL LEU ASP ASN ARG LEU GLY ARG GLU THR SEQRES 16 A 198 GLY ARG PHE SEQRES 1 B 198 MET ASP SER LEU GLN LYS GLN ASP LEU ARG ARG PRO LYS SEQRES 2 B 198 ILE HIS GLY ALA VAL GLN ALA SER PRO TYR GLN PRO PRO SEQRES 3 B 198 THR LEU ALA SER LEU GLN ARG LEU LEU TRP VAL ARG GLN SEQRES 4 B 198 ALA ALA THR LEU ASN HIS ILE ASP GLU VAL TRP PRO SER SEQRES 5 B 198 LEU PHE LEU GLY ASP ALA TYR ALA ALA ARG ASP LYS SER SEQRES 6 B 198 LYS LEU ILE GLN LEU GLY ILE THR HIS VAL VAL ASN ALA SEQRES 7 B 198 ALA ALA GLY LYS PHE GLN VAL ASP THR GLY ALA LYS PHE SEQRES 8 B 198 TYR ARG GLY MET SER LEU GLU TYR TYR GLY ILE GLU ALA SEQRES 9 B 198 ASP ASP ASN PRO PHE PHE ASP LEU SER VAL TYR PHE LEU SEQRES 10 B 198 PRO VAL ALA ARG TYR ILE ARG ALA ALA LEU SER VAL PRO SEQRES 11 B 198 GLN GLY ARG VAL LEU VAL HIS CYS ALA MET GLY VAL SER SEQRES 12 B 198 ARG SER ALA THR LEU VAL LEU ALA PHE LEU MET ILE CYS SEQRES 13 B 198 GLU ASN MET THR LEU VAL GLU ALA ILE GLN THR VAL GLN SEQRES 14 B 198 ALA HIS ARG ASN ILE CYS PRO ASN SER GLY PHE LEU ARG SEQRES 15 B 198 GLN LEU GLN VAL LEU ASP ASN ARG LEU GLY ARG GLU THR SEQRES 16 B 198 GLY ARG PHE SEQRES 1 C 198 MET ASP SER LEU GLN LYS GLN ASP LEU ARG ARG PRO LYS SEQRES 2 C 198 ILE HIS GLY ALA VAL GLN ALA SER PRO TYR GLN PRO PRO SEQRES 3 C 198 THR LEU ALA SER LEU GLN ARG LEU LEU TRP VAL ARG GLN SEQRES 4 C 198 ALA ALA THR LEU ASN HIS ILE ASP GLU VAL TRP PRO SER SEQRES 5 C 198 LEU PHE LEU GLY ASP ALA TYR ALA ALA ARG ASP LYS SER SEQRES 6 C 198 LYS LEU ILE GLN LEU GLY ILE THR HIS VAL VAL ASN ALA SEQRES 7 C 198 ALA ALA GLY LYS PHE GLN VAL ASP THR GLY ALA LYS PHE SEQRES 8 C 198 TYR ARG GLY MET SER LEU GLU TYR TYR GLY ILE GLU ALA SEQRES 9 C 198 ASP ASP ASN PRO PHE PHE ASP LEU SER VAL TYR PHE LEU SEQRES 10 C 198 PRO VAL ALA ARG TYR ILE ARG ALA ALA LEU SER VAL PRO SEQRES 11 C 198 GLN GLY ARG VAL LEU VAL HIS CYS ALA MET GLY VAL SER SEQRES 12 C 198 ARG SER ALA THR LEU VAL LEU ALA PHE LEU MET ILE CYS SEQRES 13 C 198 GLU ASN MET THR LEU VAL GLU ALA ILE GLN THR VAL GLN SEQRES 14 C 198 ALA HIS ARG ASN ILE CYS PRO ASN SER GLY PHE LEU ARG SEQRES 15 C 198 GLN LEU GLN VAL LEU ASP ASN ARG LEU GLY ARG GLU THR SEQRES 16 C 198 GLY ARG PHE SEQRES 1 D 198 MET ASP SER LEU GLN LYS GLN ASP LEU ARG ARG PRO LYS SEQRES 2 D 198 ILE HIS GLY ALA VAL GLN ALA SER PRO TYR GLN PRO PRO SEQRES 3 D 198 THR LEU ALA SER LEU GLN ARG LEU LEU TRP VAL ARG GLN SEQRES 4 D 198 ALA ALA THR LEU ASN HIS ILE ASP GLU VAL TRP PRO SER SEQRES 5 D 198 LEU PHE LEU GLY ASP ALA TYR ALA ALA ARG ASP LYS SER SEQRES 6 D 198 LYS LEU ILE GLN LEU GLY ILE THR HIS VAL VAL ASN ALA SEQRES 7 D 198 ALA ALA GLY LYS PHE GLN VAL ASP THR GLY ALA LYS PHE SEQRES 8 D 198 TYR ARG GLY MET SER LEU GLU TYR TYR GLY ILE GLU ALA SEQRES 9 D 198 ASP ASP ASN PRO PHE PHE ASP LEU SER VAL TYR PHE LEU SEQRES 10 D 198 PRO VAL ALA ARG TYR ILE ARG ALA ALA LEU SER VAL PRO SEQRES 11 D 198 GLN GLY ARG VAL LEU VAL HIS CYS ALA MET GLY VAL SER SEQRES 12 D 198 ARG SER ALA THR LEU VAL LEU ALA PHE LEU MET ILE CYS SEQRES 13 D 198 GLU ASN MET THR LEU VAL GLU ALA ILE GLN THR VAL GLN SEQRES 14 D 198 ALA HIS ARG ASN ILE CYS PRO ASN SER GLY PHE LEU ARG SEQRES 15 D 198 GLN LEU GLN VAL LEU ASP ASN ARG LEU GLY ARG GLU THR SEQRES 16 D 198 GLY ARG PHE FORMUL 5 HOH *260(H2 O) HELIX 1 1 THR A 27 ARG A 38 1 12 HELIX 2 2 ASP A 57 ASP A 63 1 7 HELIX 3 3 ASP A 63 LEU A 70 1 8 HELIX 4 4 THR A 87 TYR A 92 1 6 HELIX 5 5 LEU A 112 VAL A 114 5 3 HELIX 6 6 TYR A 115 SER A 128 1 14 HELIX 7 7 SER A 143 GLU A 157 1 15 HELIX 8 8 THR A 160 ALA A 170 1 11 HELIX 9 9 ASN A 177 ARG A 193 1 17 HELIX 10 10 THR B 27 VAL B 37 1 11 HELIX 11 11 ASP B 57 ARG B 62 1 6 HELIX 12 12 ASP B 63 GLY B 71 1 9 HELIX 13 13 THR B 87 TYR B 92 1 6 HELIX 14 14 ASP B 111 VAL B 114 5 4 HELIX 15 15 TYR B 115 SER B 128 1 14 HELIX 16 16 SER B 143 GLU B 157 1 15 HELIX 17 17 THR B 160 ALA B 170 1 11 HELIX 18 18 ASN B 177 GLY B 192 1 16 HELIX 19 19 THR C 27 ARG C 38 1 12 HELIX 20 20 ASP C 57 ASP C 63 1 7 HELIX 21 21 ASP C 63 GLY C 71 1 9 HELIX 22 22 THR C 87 TYR C 92 1 6 HELIX 23 23 LEU C 112 LEU C 127 1 16 HELIX 24 24 SER C 143 ASN C 158 1 16 HELIX 25 25 THR C 160 ALA C 170 1 11 HELIX 26 26 ASN C 177 THR C 195 1 19 HELIX 27 27 THR D 27 ARG D 38 1 12 HELIX 28 28 ASP D 57 ASP D 63 1 7 HELIX 29 29 ASP D 63 GLY D 71 1 9 HELIX 30 30 THR D 87 TYR D 92 1 6 HELIX 31 31 LEU D 112 SER D 128 1 17 HELIX 32 32 SER D 143 GLU D 157 1 15 HELIX 33 33 THR D 160 ALA D 170 1 11 HELIX 34 34 ASN D 177 THR D 195 1 19 SHEET 1 A 2 THR A 42 ASN A 44 0 SHEET 2 A 2 THR B 42 ASN B 44 -1 O LEU B 43 N LEU A 43 SHEET 1 B 5 ILE A 46 TRP A 50 0 SHEET 2 B 5 LEU A 53 GLY A 56 -1 O LEU A 53 N TRP A 50 SHEET 3 B 5 VAL A 134 HIS A 137 1 O VAL A 134 N PHE A 54 SHEET 4 B 5 HIS A 74 ASN A 77 1 N VAL A 76 O LEU A 135 SHEET 5 B 5 GLU A 98 GLY A 101 1 O GLU A 98 N VAL A 75 SHEET 1 C 5 ILE B 46 TRP B 50 0 SHEET 2 C 5 LEU B 53 GLY B 56 -1 O LEU B 53 N TRP B 50 SHEET 3 C 5 VAL B 134 HIS B 137 1 O VAL B 134 N PHE B 54 SHEET 4 C 5 HIS B 74 ASN B 77 1 N VAL B 76 O LEU B 135 SHEET 5 C 5 GLU B 98 GLY B 101 1 O GLU B 98 N VAL B 75 SHEET 1 D 2 THR C 42 ASN C 44 0 SHEET 2 D 2 THR D 42 ASN D 44 -1 O LEU D 43 N LEU C 43 SHEET 1 E 5 ILE C 46 TRP C 50 0 SHEET 2 E 5 LEU C 53 GLY C 56 -1 O LEU C 53 N TRP C 50 SHEET 3 E 5 VAL C 134 HIS C 137 1 O VAL C 134 N PHE C 54 SHEET 4 E 5 HIS C 74 ASN C 77 1 N VAL C 76 O LEU C 135 SHEET 5 E 5 GLU C 98 GLY C 101 1 O TYR C 100 N ASN C 77 SHEET 1 F 5 ILE D 46 TRP D 50 0 SHEET 2 F 5 LEU D 53 GLY D 56 -1 O LEU D 53 N TRP D 50 SHEET 3 F 5 VAL D 134 HIS D 137 1 O VAL D 134 N PHE D 54 SHEET 4 F 5 HIS D 74 ASN D 77 1 N VAL D 76 O LEU D 135 SHEET 5 F 5 GLU D 98 GLY D 101 1 O GLU D 98 N VAL D 75 CRYST1 61.586 72.240 89.896 90.00 99.66 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016237 0.000000 0.002764 0.00000 SCALE2 0.000000 0.013843 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011284 0.00000